A narrative review synthesizing evidence on rapid diagnostic methods for pathogen identification and resistance detection, offering expert synthesis rather than original clinical trial data or definitive quantitative evidence of practice impact.
This is an early-stage screening study identifying fungal strains with potential to produce bioactive compounds; it demonstrates feasibility but lacks clinical validation, quantified effect sizes, or comparison to known standards.
Descriptive genomic and molecular characterization of 35 clinical strains with no comparator, control group, or clinical outcome measure; establishes baseline resistance and virulence profiles but does not test an intervention or hypothesis with inferential statistics.